1-3 of 3
Marcus Järås
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity

Maria Rodriguez-Zabala, Ramprasad Ramakrishnan, Katrin Reinbach, Somadri Ghosh, Leal Oburoglu, Antoni Falqués-Costa, Kishan Bellamkonda, Mats Ehinger, Pablo Peña-Martínez, Noelia Puente-Moncada, Henrik Lilljebjörn, Jörg Cammenga, Cornelis Jan Pronk, Vladimir Lazarevic, Thoas Fioretos, Anna K. Hagström-Andersson, Niels-Bjarne Woods, Marcus Järås
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5382–5395.
https://doi.org/10.1182/bloodadvances.2023009967
Published: 2023
Includes: Supplemental data
Journal Articles

The complement receptor C3AR constitutes a novel therapeutic target in NPM1 -mutated AML

Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez, Noelia Puente-Moncada, Carl Sandén, Anna M. Blom, Rasmus Henningsson, Gunnar Juliusson, Ben King, Niklas Landberg, Vladimir Lazarevic, Christina Orsmark-Pietras, Marianne Rissler, Vendela Rissler, Helena Ågerstam, Marcus Järås, Henrik Lilljebjörn, Thoas Fioretos
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1204–1218.
https://doi.org/10.1182/bloodadvances.2022007682
Published: 2023
Includes: Supplemental data
Journal Articles

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells

Mia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Gabriella Glowacki, Christina Orsmark-Pietras, Talía Velasco-Hernández, Vladimir Lj Lazarević, Gunnar Juliusson, Jörg Cammenga, James C. Mulloy, Johan Richter, Thoas Fioretos, Benjamin L. Ebert, Marcus Järås
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2046–2057.
https://doi.org/10.1182/bloodadvances.2017006148
Published: 2017
Includes: Supplemental data